Scientific articles 29 Apr 2025 Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study The Lancet Global Health
Scientific articles 29 Apr 2025 Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study The Lancet Global Health
News 25 Apr 2025 Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
In the media 23 Apr 2025 Race against time: New treatment for deadly HIV complication enters trials Daily Nation
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Scientific articles 21 Apr 2025 A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2025 Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network The Lancet Child & Adolescent Health
In the media 17 Apr 2025 New treatment for deadly HIV-linked meningitis enters phase II trial The Standard
In the media 17 Apr 2025 Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai RTS
In the media 16 Apr 2025 Accord historique à l’OMS sur la préparation et la lutte contre les futures pandémies AFP
In the media 16 Apr 2025 Luz verde para un “histórico” tratado mundial contra pandemias impulsado por la OMS El País
Press releases 4 Apr 2023 Dutch Postcode Lottery supports DNDi’s efforts to develop new treatments for children affected by neglected diseases
Press releases 30 Mar 2023 Eumycetoma: DNDi welcomes Japan’s GHIT Fund support for registration of new treatment for deeply neglected fungal disease
Press releases 2 Feb 2023 Dutch government renews support to DNDi projects on poverty-related diseases that disproportionately impact women
Press releases 14 Dec 2022 Launch of first platform for emergency research preparedness and response in Africa
Press releases 1 Dec 2022 DNDi partners in a new NIHR-funded Global Health Research Group on HIV-associated Fungal Infections (IMPRINT)
Press releases 30 Nov 2022 Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Press releases 15 Nov 2022 Leishmaniasis project launched in Eastern Africa to improve patient access to treatments
Press releases 6 Oct 2022 Le Canton de Genève soutient la recherche sur le mycétome, l’une des maladies les plus négligées au monde
Press releases 29 Sep 2022 Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa
Press releases 5 Sep 2022 Dr Luis Pizarro becomes new Executive Director of the Drugs for Neglected Diseases initiative
Press releases 30 Aug 2022 Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and DNDi to explore joint opportunities to develop affordable and life-saving new drugs for neglected tropical diseases
Press releases 3 Aug 2022 Network of experts calls for urgent boost to research and development of rapid tests for cutaneous leishmaniasis in Latin America
Press releases 27 Jul 2022 Korean cutting-edge technology to reduce the cost of promising drug for neglected disease visceral leishmaniasis
Press releases 6 Jul 2022 Wellcome renews partnership with DNDi to develop new generation drugs to treat leishmaniasis
Press releases 5 Jul 2022 Brazil joins ANTICOV trial to find early treatments for people with mild-to-moderate COVID-19